Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection recall
FDA recall D-0325-2024 · initiated Jan 22, 2024
IntegraDose Compounding Services LLC recalled Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection in Jan 2024 — an FDA Class II recall (D-0325-2024) because Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1,299 syringes
Details
- Product
- Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
- Recalling company
- IntegraDose Compounding Services LLC
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- MN
- Initiated
- Jan 22, 2024
- FDA report date
- Feb 21, 2024
Frequently asked
- Was Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection recalled?
- IntegraDose Compounding Services LLC recalled Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection in Jan 2024 — an FDA Class II recall (D-0325-2024) because Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0325-2024 was: Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
- Is a recalled Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection are affected?
- Distributed: MN. The recall covers these lots — Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0325-2024.